April 1 (Reuters) - GlaxoSmithKline PLC:
* GLAXOSMITHKLINE PLC - GSK - SEGMENT AND PRODUCT SALES REPORTING CHANGES
* GSK: FROM Q1 2022 RESULTS GSK WILL REPORT RESULTS UNDER THREE SEGMENTS
* GSK - CONSUMER HEALTHCARE SEGMENT WILL BE REPORTED AS A “CONTINUING OPERATION” UNTIL SUCH TIME AS FORMAL CRITERIA FOR TREATING IT OTHERWISE
* GSK - SALES OF BRANDS DIVESTED IN Q1 2021 WILL NOT BE REPORTED IN SEPARATE BRANDS DIVESTED CATEGORY FOR COMPARATIVE PERIODS OF 2021
* GSK - AS A RESULT OF CHANGES, FROM Q1 2022 PRESENTATION OF A SEPARATE CATEGORY FOR BRANDS DIVESTED AND UNDER REVIEW WILL NO LONGER BE REQUIRED
* GSK: THREE PRODUCT GROUPS WILL BE SPECIALTY MEDICINES PRODUCTS, GENERAL MEDICINES PRODUCTS, AND VACCINES PRODUCTS Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.